Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference
Get Alerts XERS Hot Sheet
Join SI Premium – FREE
CHICAGO--(BUSINESS WIRE)-- Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies, today announced that members of its senior management will participate in a fireside chat at the upcoming Piper Sandler 36th Annual Healthcare Conference on December 3, 2024 at 8:00am Eastern Time.
A live webcast of the event will be available on the 'Events & Presentations' section of Xeris’ Investor Relations website at www.xerispharma.com. A replay of the webcast will be available for 30 days.
About Xeris
Xeris (Nasdaq: XERS) is a growth-oriented biopharmaceutical company committed to improving patients' lives by developing and commercializing innovative products across a range of therapies. Xeris has three commercially available products: Recorlev®, for the treatment of endogenous Cushing’s syndrome; Gvoke®, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis®, a proven therapy for primary periodic paralysis. Xeris also has a pipeline of development programs to bring new products forward using its proprietary formulation technology platforms, XeriSol® and XeriJect®, supporting long-term product development and commercial success.
Xeris Biopharma Holdings is headquartered in Chicago, IL. For more information, visit www.xerispharma.com, or follow us on X, LinkedIn, or Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241125772487/en/
Investor Contact
Allison Wey
Senior Vice President, Investor Relations and Corporate Communications
[email protected]
Source: Xeris Biopharma
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 2026 CIFTIS Engineering Consulting & Construction Services Section to Open Soon
- XRP Price Prediction 2027, 2030, 2040: XRP Eyes $3.84 Comeback While Apeing Targets the Next Crypto to Explode With 10,000% ROI
- “Dream Pursuers in the Greater Bay Area – Shenzhen APEC Tech Discovery Tour” Wrapped Up Successfully
Create E-mail Alert Related Categories
Business Wire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share